01-01-1970 12:00 AM | Source: Accord Fintech
India's Sun Pharma posts nearly 30% rise in Q4 profit
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Sun Pharmaceutical Industries Ltd, India's largest drugmaker by revenue, on Friday reported a 29.6% rise in fourth-quarter profit, as it benefited from lower expenses.
The company's consolidated profit before exceptional items and tax rose to 24.11 billion rupees ($291.7 million) for the quarter ended March 31, it said in an exchange filing.
Input costs declined 13.2% for the quarter.
($1 = 82.6420 Indian rupees)
Latest News
Evening Roundup : A Daily Report on Bullion Energy &...
Market Wrap Up by Shrikant Chouhan, Head Equity Rese...
Gold Special Report: Akshaya Tritiya 2024 by Religar...
FIIs stood as net sellers in equities as per May 09 ...
Perspective On AMFI Data by Sanjay Agarwal, Senior D...
Post market comment by Mandar Bhojane, Research Anal...
Daily Market Analysis : The market resumed its corre...
Indian shares drop most in three months; L&T drags
VC firm Venturi Partners invests $27 mn in K12 Techn...
TCS CEO Krithivasan earned $3 million in first year ...
